Product
Sodium Nitroprusside
7 clinical trials
16 indications
Indication
Vasodilatory Effects of C21Indication
Insulin ResistanceIndication
HealthyIndication
ObesityIndication
Hot FlashesIndication
MenopauseIndication
Vasomotor SystemIndication
OestrogenIndication
Cardiovascular DiseasesIndication
MicrovasculatureIndication
SchizophreniaIndication
Schizoaffective DisorderIndication
VasodilationIndication
VasoconstrictionIndication
Spinal Cord InjuriesIndication
Endothelial dysfunctionClinical trial
A Phase 1, Open-label, Single-centre Study Investigating the Effect of C21 on Forearm Blood Flow in Healthy Male Subjects by Use of Strain-gauge Venous Occlusion PlethysmographyStatus: Completed, Estimated PCD: 2022-05-11
Clinical trial
Vanderbilt University Medical CenterStatus: Active (not recruiting), Estimated PCD: 2025-11-30
Clinical trial
Hot Flashes and Neurovascular Function in WomenStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Sex-specific Effects of Continuous Estrogen on Human in Vivo Microvascular FunctionStatus: Recruiting, Estimated PCD: 2029-12-01
Clinical trial
Proof of Mechanism Study Using a Retinal Biomarker to Predict Treatment Response With Intravenous Sodium Nitroprusside in Symptomatic Early Course SchizophreniaStatus: Recruiting, Estimated PCD: 2024-12-21
Clinical trial
Sex Differences in Sympathetic Vascular Reactivity at High AltitudeStatus: Completed, Estimated PCD: 2023-02-05
Clinical trial
Role of Vascular Endothelial Function After Spinal Cord Injury Related Cardiovascular Disease RiskStatus: Recruiting, Estimated PCD: 2027-03-30